MeSH tree: D03.383.129.708
A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, according to a study led by the University of Oxford.
Jun 30, 2025
0
53
Researchers at the University of Tsukuba have found that thiamine (vitamin B1) tetrahydrofurfuryl disulfide (TTFD), a common thiamine derivative, can induce arousal. TTFD is chemically modified to improve tissue penetration ...
May 16, 2025
0
50
The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard treatment for amyotrophic lateral sclerosis slowed functional decline and extended the lifespan of people ...
May 13, 2025
0
71
An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which is central to the regulation ...
May 6, 2025
0
116
Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball player—is a progressive neurodegenerative disease that affects thousands of Americans every year. ALS remains ...
May 5, 2025
0
21
A number of videos have surfaced recently on social media with women claiming that common medications used to treat allergies and heartburn have helped them manage symptoms of premenstrual dysphoric disorder (PMDD). But is ...
Apr 10, 2025
0
24
Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Mar 20, 2025
0
53
If you head to the shops to buy bread, you'll face a variety of different options.
Mar 5, 2025
0
19
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), which remove old (senescent) ...
Feb 26, 2025
0
54
Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, according to a study in preclinical models led by researchers at UT Southwestern Medical Center. The ...
Feb 25, 2025
0
24
